Related Experiment Video
Updated: Mar 11, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Regulatory non-coding RNAs in acute myocardial infarction
Yuan Guo1, Fei Luo1, Qiong Liu1
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
This review explores non-coding RNAs (ncRNAs) in acute myocardial infarction (AMI). It highlights how microRNAs, long ncRNAs, and circular RNAs offer novel therapeutic targets for this common cardiovascular disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Medicine
Background:
- Acute myocardial infarction (AMI) is a leading cause of global mortality and morbidity.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their roles in cardiovascular diseases.
- MicroRNAs (miRNAs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs) are key ncRNA types implicated in AMI pathogenesis.
Purpose of the Study:
- To systematically review the current understanding of ncRNA functions in AMI.
- To elucidate the novel regulatory mechanisms employed by ncRNAs in AMI.
- To highlight the therapeutic potential of ncRNAs for treating AMI.
Main Methods:
- Literature review of recent scientific findings on ncRNAs in AMI.
- Summary of established and emerging mechanisms of ncRNA action.
- Analysis of potential therapeutic applications of ncRNAs in AMI.
Main Results:
- ncRNAs, including miRNAs, lncRNAs, and circRNAs, significantly modulate key pathological processes in AMI.
- These processes include cardiomyocyte apoptosis, inflammation, angiogenesis, and fibrosis.
- Novel mechanisms of ncRNA regulation in AMI are being uncovered.
Conclusions:
- ncRNAs play critical roles in the pathophysiology of AMI.
- Understanding ncRNA mechanisms provides insights into disease progression.
- ncRNAs represent promising therapeutic targets for managing AMI.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care
lncRNA - Long Non-coding RNAs

